MetaCap

Pediatrix Medical Group Inc. (MD)

NYSE: MDHealth CareHospital/Nursing ManagementUSD

30.22+0.28 (+0.94%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MD stock chart

Technical analysis

Key statistics

All statistics
52-week range
17.23 – 33.74
Day range
29.89 – 30.43
Volume / Avg
790.97K / 709.48K
Beta
—

52-week range

$17.23$33.74

MD stock today

On Nov 20, MD ended the session at $30.22, adding $0.28 (0.94%), versus the S&P 500's 3.70% decline. Shares are 10.4% below their 52-week high of $33.74, set on Nov 5, 2026 and 75.4% above the 52-week low of $17.23, in the middle of the past year's range. MD is up 41.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 30.8%.

At 16.5x trailing earnings, Pediatrix Medical Group trades in line with the peer-group median of 16.7x. Its forward P/E of 12.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Pediatrix Medical Group

Company profile

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program.

Industry
Hospital/Nursing Management
CEO
Mr. Mark S. Ordan
Headquarters
Sunrise, FL
Employees
4,280

Financial highlights

Full financials

In fiscal 2025, Pediatrix Medical Group generated $1.91 billion in revenue, down 4.9% from fiscal 2024, its first annual decline since 2020. Net income was $165.4 million, for a net margin of 8.6% versus a median of -3.0% in the prior 5 years. Operating margin was 10.9%.

Pediatrix Medical Group annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$1.91B$2.01B$1.99B$1.97B$1.91B
Growth-4.92%+0.92%+1.15%+3.18%+10.22%
Net income$165.39M$-99.07M$-60.41M$66.33M$130.96M
EPS (diluted)$1.94$-1.19$-0.73$0.79$1.53

Analyst forecast

Forecast

Consensus (7 analysts)

hold

Avg. price target

$30.08-0.46%

  • Strong buy 0
  • Buy 1
  • Hold 5
  • Sell 1
  • Strong sell 0

Target range

Low $28.00High $33.50

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$0.59 vs $0.59

MD news

All MD news

Pediatrix Medical Group peers

Health Care sector
MD peer companies
CompanyPrice% ChgMarket capCompare
BKDBrookdale Senior Living Inc.8.86+1.96%$2.12Bvs MD
ARDTArdent Health Inc.15.08+4.00%$2.10Bvs MD
NHCNational HealthCare Corporation190.77+1.18%$2.99Bvs MD
HCSGHealthcare Services Group Inc.24.72-0.20%$1.67Bvs MD
SNDASonida Senior Living Inc.31.47-0.57%$1.55Bvs MD
SGRYSurgery Partners Inc.26.78+0.34%$3.50Bvs MD
CYHCommunity Health Systems Inc.1.62+0.62%$228.46Mvs MD
PACSPACS Group Inc.43.67+1.49%$6.93Bvs MD

Indexes, lists and sector

Pediatrix Medical Group stock FAQ

What is Pediatrix Medical Group's stock price today?

MD last traded at $30.22 as of Nov 20, 4:00 PM EST, up 0.94% on the day. Prices are delayed at least 15 minutes.

Does Pediatrix Medical Group pay a dividend?

No. Pediatrix Medical Group does not currently pay a regular cash dividend.

What is MD's P/E ratio?

MD trades at a trailing P/E ratio of 16.51 and a forward P/E of 12.05, compared with a median of 16.7 for its closest peers.

Who is Pediatrix Medical Group's CEO?

Mr. Mark S. Ordan is the chief executive officer of Pediatrix Medical Group Inc., which has about 4,280 employees.

Has MD ever split its stock?

Yes. The most recent MD stock split was a 2-for-1 split on Dec 20, 2013, one of 2 splits on record.

What is the MD 52-week high?

The 52-week high for MD is $33.74 and the 52-week low is $17.23. The stock is currently 10.4% below its high.

Compare MD